Centre for Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx)

28 Jan 2026
Precision Medicine & Patient Stratification Stage
  • Regulation is important in the implementation of pharmacogenomics into clinical practice. 

  • Regulatory pathways for pharmacogenomics are complicated and sometimes unclear, largely because they are derived from an era where genomics was a pipe dream 

  • The CERSI-PGx has been working with regulators to develop proportionate, patient-focused, inclusive and forward-looking regulatory pathways to facilitate pharmacogenomics innovation and implementation. 

Speakers
Sir Munir Pirmohamed
Sir Munir Pirmohamed, Chair of Pharmacogenetics - University of Liverpool